FEBS3+ Meeting: 86th Harden Conference - Machines on Genes
22-26 May 2022 Abstract deadline: 22 March 2022. Earlybird registration deadline: 22 March 2022. THIS EVENT IS FULLY BOOKED. Registration is open - please note places at this meeting are limited to a maximum of 120 people From bacteria to eukaryotes, cells have evolved a remarkable battery of enzymes to deal with the mechanical and topological challenges presented by nucleic acid production, processing and maintenance. A clear view of the biology of the genetic material requires a molecular understanding of how these enzymes function. Such an understanding will enhance our ability to manipulate genome structure and gene expression. The theme of this meeting revolves around the mechanisms of these enzymes, with particular emphasis on research that integrates structural, biochemical, biophysical and computational approaches. With recent technological advances in imaging (i.e., single-molecule and cryo-electron microscopies), we expect to witness a flourish of key biological systems to be characterised with unprecedented detail. This meeting will cover many of the molecular mechanisms by which large macromolecular machines carry out a diverse range of nucleic acid processes including DNA replication and repair, gene transcription and regulation, RNA processing and splicing, translation, nucleic acids structures and chromatin structure and epigenetic mechanisms. The meeting will also explore new quantitative techniques as well as theoretical approaches. Invited speakers include: Oral communication slots are available at this meeting. All attendees, particularly researchers in the early stages of their career, are invited to submit a poster abstract for consideration as an oral communication. You can submit your abstract here. Please note that Harden Conferences are ‘fully residential only’ retreat-style conferences to encourage networking and discussion outside of the lectures. As such, all registration fees include onsite accommodation and it is not possible to offer a registration fee without accommodation. There are a variety of Biochemical Society, NVBMB and SEBBM bursaries available for this meeting. Click here to find out more. Not a member of the Biochemical Society? Join today and save up to 100€ on your registration fee. Places at this meeting are limited; book early to avoid disappointment!
Interested in sponsoring, exhibiting or advertising at the meeting? We have a variety of packages available. Please contact us for more details.
This meeting is being organised by the Biochemical Society in collaboration with NVBMB (The Netherlands) and SEBBM (Spain) as a FEBS 3+ meeting. The FEBS3+ Meetings programme was established by FEBS to support scientific meetings, organised through collaboration of at least three FEBS Constituent Societies. The aim of the programme is to increase international collaboration between molecular life scientists in a subset of countries within the FEBS area, while also encouraging sharing of expertise and efforts. These events are generously supported by FEBS. A FEBS3+ travel award scheme is also available to young scientists living outside of the UK who are members of SEBBM or NVBMB. More information can be found here. COVID-19 (coronavirus) The Biochemical Society has been monitoring developments and advice from the UK Government and World Health Organisation (WHO) since the emergence of the novel coronavirus (SARS-CoV-2) in January. The Biochemical Society has taken the decision to postpone or cancel all of its its face-to-face scientific meetings and training events scheduled in 2020. This difficult decision has been made by the Society’s Council of Trustees in light of the developing situation both within the UK and worldwide. To read more on this click here. This event initially planned for the 3-7 May 2020 has been rescheduled for 22-26 May 2022. Covid policy Click here to see the Biochemical Society's Covid policy for events.* *Please note we’re monitoring UK government and local guidance and will adapt our plans as necessary. The guidance above is therefore subject to change.
|
